Tag

District Court Archives - Carey Danis & Lowe

Boston Scientific Delays, Vaginal Mesh Lawsuits Return to State Courts

By | Defective Medical Device litigation, Transvaginal Mesh, Uncategorized

boston_scientifi_transvaginal_mesh_lawsuitIn late October 2015, a federal judge denied a request made by Boston Scientific, a manufacturer of vaginal mesh devices. The company sought to move 62 transvaginal mesh lawsuits, which were filed as a single multi-plaintiff suit, into a multidistrict litigation (MDL).

An MDL concerning transvaginal mesh injuries and Boston Scientific mesh products exists in a West Virginia federal court. The MDL is In re: Boston Scientific Corp., Pelvic Repair System Products Liability Litigation, MDL No. 2326, managed by Judge Joseph R. Goodwin in the U.S. District Court for the Southern District of West Virginia in Charleston.

The federal judge who denied Boston Scientific’s request stated that the company waited too long to move the lawsuits from state to federal court. In California, U.S. District Judge Beverly Reid O’Connell said that Boston Scientific should’ve issued their request within a year of the lawsuit’s original file date.

Since they waited too long, a state court judge has since separated the individual mesh lawsuits, and sent them back to courts in their state of origin.

This is an unfortunate turn of events for these plaintiffs. Consolidation into the MDL would bring them all one step closer to putting this difficult chapter in their lives behind them.

You don’t have to suffer alone.

We are here to help you. If you or a loved one suffered from a transvaginal mesh injury, we encourage you to explore your legal options.

Carey Danis & Lowe offers free case evaluations, during which we can discuss your compensation eligibility, and whether filing a vaginal mesh lawsuit is right for you.

Call Carey Danis & Lowe today ― 800.721.2519.

You can also reach us online by completing a confidential personal injury claim form.

 

You may be interested in reading…

A June Meeting for Consolidated Vaginal Mesh Lawsuits

By | Defective Medical Device litigation, Transvaginal Mesh, Uncategorized

Boston Scientific Ordered to Release Defective Transvaginal Mesh DocumentsBoston Scientific Ordered to Release Defective Transvaginal Mesh DocumentsWhen Judge Goodwin said he was going to “kick it into high gear”, he really meant it.

According to a pretrial order (PTO) filed in early April 2015, Judge Joseph R. Goodwin scheduled a status conference for 6 of 7 transvaginal mesh multidistrict litigations (MDLs) being heard in the U.S. District Court for the Southern District of West Virginia.

Representatives for plaintiffs and defendants will meet on June 2, 2015.

In the PTO, the court scheduled each MDL for about an hour-long meeting. The meeting schedule for June 2 is as follows:

  • 10:00 am – C.R. Bard MDL 2187
  • 11:00 am – Boston Scientific MDL 2326
  • 1:30 pm – Ethicon MDL 2327
  • 2:30 pm – Coloplast MDL 2387
  • 3:00 pm – Cook MDL 2440

The transvaginal mesh lawyers at Carey Danis & Lowe are pleased to see Judge Goodwin’s drive to keep each of these MDLs on track.

We Can Help You

Carey Danis & Lowe currently represents women who’ve been injured by transvaginal mesh products manufactured by C.R. Bard, Boston Scientific, Ethicon, Coloplast, and Cook.

If you have suffered from any serious transvaginal mesh side effects, such as chronic pain or mesh erosion, we encourage you to begin exploring your legal options.

Free Case Evaluations

During your free case evaluation, one of our defective medical device lawyers will guide you through your legal options, compensation eligibility, and if applicable, the process of filing a vaginal mesh lawsuit.

 

Upcoming Meetings in Testosterone Litigation in Illinois

By | Pharmaceutical litigation, Testosterone, Uncategorized

testosterone gel lawsuitPretrial proceedings are going smoothly in the testosterone multidistrict litigation (MDL) that is being held in an Illinois federal court. The testosterone MDL is scheduled to meet three times this spring, with the next meeting scheduled for March 20, 2015.

The U.S. District Court for the Northern District of Illinois has also scheduled case management conferences on April 21 and on May 19.

The MDL currently has 1,247 pending testosterone lawsuits.

The plaintiffs involved in the MDL are men who have been injured by testosterone products, including testosterone gel, such as Androgel, a product manufactured by AbbVie.

Studies have shown that testosterone use in older male patients who are using the hormone to treat signs of male aging, such as decreased muscle mass, energy, and libido, have an increased risk of cardiovascular complications, including heart attack or stroke.

On March 3, 2015, the U.S. Food and Drug Administration (FDA) released a statement ordering manufacturers of testosterone products to update their labeling to include information on cardiovascular risks. The FDA also noted in their statement that the agency has not yet approved the use of testosterone to treat male aging, and has only approved these kinds of products to treat patients with medical conditions that cause low testosterone levels.

Legal Help for Men Injured by Testosterone Gels

Carey Danis & Lowe is a national law firm with headquarters in St. Louis that specializes in defective drug litigation. Our dedicated team of personal injury lawyers are currently representing men in testosterone gel lawsuits. If you or someone you love has suffered from a testosterone injury, contact our law offices for a free, no obligation case evaluation.

Carey Danis & Lowe is here is here to listen to you. Call our law firm at 800.721.2519, or complete a confidential personal injury claim form.

We look forward to offering you any legal and/or medical assistance that we can.

Continue to read the Carey Danis & Lowe law blog, and stay current on testosterone lawsuit news. You might be interested in reading:

FDA Warns about Using Testosterone for Aging

Testosterone Gel & Its Risks

 

800 GMO Corn Lawsuits from 20 States

By | Consumer protection, GMO, Product Liability, Uncategorized

gmocornseedlawsuitU.S. corn growers are taking a stand against biotechnology companies by filing GMO corn lawsuits. There are approximately 800 pending lawsuits from 20 states. In late January, a judicial panel ruled to consolidate a portion of these lawsuits into a multidistrict litigation (MDL) under the management of Judge John Lungstrum in a U.S. District Court in Kansas.

The farmers behind these 800 GMO corn lawsuits claim to have suffered financial losses somewhere between $1 – $2.9 billion.

According to Arkansas Business, farmers growing non-GMO corn have also suffered financially as a result of cross-pollination.

These GMO corn seed lawsuits concern a genetically-modified corn seed developed by a Swiss biotechnology company, Syngenta. The GMO corn seed is Agrisure Viptera, or MIR 162.

Though China now accepts imports of corn products grown by using Agrisure Viptera seeds, this was not always the case. A major trade partner, China’s refusal of Agrisure Viptera corn products caused substantial financial damage to U.S. corn growers.

Losses from GMO Corn?

If you suffered losses from GMO corn, we can help. Carey Danis & Lowe is a St. Louis-based law firm that currently represents farmers in GMO corn lawsuits in Missouri and other corn-growing states. Our dedicated team of attorneys work diligently to recover losses for clients.

We encourage you to begin exploring your legal options and compensation eligibility today. Carey Danis & Lowe offers free, no obligation case evaluations. Find out if you should file a GMO corn lawsuit.

Contact Carey Danis & Lowe today by calling 800.721.2519, or by completing a confidential claim form.

Transvaginal Mesh Lawsuit Update: C.R. Bard Settles a Case

By | Defective Medical Device litigation, Transvaginal Mesh, Uncategorized

transvaginalmeshlawsuitC.R. Bard, a manufacturer of medical devices used to treat pelvic organ prolapse (POP) and stress urinary incontinence (SUI), recently settled a vaginal mesh lawsuit. Selected as a bellwether case, the lawsuit involved the plaintiff, Debra Wise.

The bellwether trial was scheduled to begin on February 18, 2015 in the U.S. District Court for the Southern District of West Virginia as part of the C.R. Bard multidistrict litigation (MDL).

According to a report by Reuters on C.R. Bard’s decision, the settlement amount is unknown.

The fact that C.R. Bard decided to settle a bellwether case is a positive sign for plaintiffs.

Additionally, the mesh manufacturer’s decision could have been influenced by the presiding judge. Carey Danis & Lowe recently reported that Judge Joseph R. Goodwin, who is overseeing the 7 mesh MDLs, urged mesh manufacturers to consider settling the tens of thousands of pending transvaginal mesh lawsuits.

Legal Assistance

If you or someone you love sustained an injury due to vaginal mesh complications, such as mesh erosion, Carey Danis & Lowe is here to help. During a free, no obligation case evaluation, we will guide you through your legal options, and determine your compensation eligibility.

Contact Carey Danis & Lowe today by phone at 800.721.2519, or by completing a confidential personal injury claim form.

Carey Danis & Lowe Reports on Syngenta GMO Corn Transfer Order

By | Class Action, Consumer protection, GMO, Uncategorized

Published December 23, 2014 on PR Web

St. Louis, Missouri (PRWEB) December 23, 2014

GMO Corn Seed LawsuitsGMO corn cases filed across the United States, and targeting Swiss biotechnology company, Syngenta, are in the process of being consolidated in a Kansas federal court for pretrial proceedings. The consolidated case is In Re: Syngenta AG MIR 162 Corn Litigation, MDL No. 2591 in the U.S. District Court for the District of Kansas.

Management of the Syngenta GMO corn multidistrict litigation (MDL) has been handed over to U.S. District Judge John W. Lungstrum.*
As a Missouri law firm specializing in class action lawsuits, and currently representing U.S. corn farmers who claim to have suffered financially from Syngenta’s genetically-modified corn seed, Agrisure Viptera, or MIR 162, the team at Carey Danis & Lowe remains abreast of news that impacts U.S. corn farmers.

Carey Danis & Lowe believes that the Judicial Panel on Multidistrict Litigation (JPML) made a sound decision in ordering Syngenta GMO corn lawsuits to be centralized in one court. In the JPML’s transfer order, a reason given for ordering the centralization is to avoid redundant research and evidence gathering, the possibility of varying pretrial rulings, and overuse of defendant and plaintiff resources.

In all, the centralization of the Syngenta lawsuits will lead to an organized and efficient legal process, which is best for all parties involved, say Carey Danis & Lowe class action attorneys.

Legal Assistance for U.S. Corn Farmers & Exporters

As the St. Louis law firm currently represents U.S. corn farmers in cases involving claims against Syngenta, Carey Danis & Lowe is available to review legal options and compensation eligibility with U.S. corn farmers and exporters who claim lost revenue from Syngenta’s commercialization of the genetically-modified corn seed, Agrisure Viptera.

Carey Danis & Lowe can be reached by phone at 800.721.2519.

——————————————

About Carey Danis & Lowe

Carey Danis & Lowe is a plaintiff’s litigation firm based in St. Louis, Missouri with law offices across the United States in Illinois, Missouri, and Florida. Carey Danis & Lowe specializes in class action lawsuits. The Carey Danis & Lowe team is comprised of experienced attorneys working alongside knowledgeable and professional staff that includes medical doctors, nurses, and information technology specialists. Contact Carey Danis & Lowe at 800.721.2519 for more information about their legal services.

 

Source
United States Judicial Panel on Multidistrict Litigation, “In Re: Syngenta AG MIR 162 Corn Litigation, Transfer Order”, December 11, 2014: http://bit.ly/jpml-syngenta-transfer-order

Carey Danis & Lowe Weighs in on Testosterone Gel Safety

By | Pharmaceutical litigation, Testosterone, Uncategorized

St. Louis, Missouri (PRWEB) November 25, 2014

testosteroneAs a personal injury law firm with a focus on defective drug law, Carey Danis & Lowe have remained abreast of the news circulating on the topic of testosterone gel and testosterone-replacement therapy as they relate to patient health and safety. Testosterone gels have been placed under increased scrutiny over the past year, in large part due to a study published in the Journal of the American Medical Association (JAMA) in November 2013 whose findings showed an increase in the risk of heart attack and stroke in study participants who used testosterone.

Carey Danis & Lowe contends that, perhaps in response to the JAMA study, the Food and Drug Administration (FDA) recently made steps to address testosterone gel safety through appointing an advisory panel. This special panel of experts released their recommendations to the FDA in September 2014.

According to an article published by the Wall Street Journal in late October 2014, the panel recommended that the FDA complete two actions, the first to order drug makers to conduct studies on their particular testosterone products as they relate to cardiovascular health, and the second, to update testosterone product labeling to reflect the reality that extensive research does not exist validating the safety of testosterone products to treat low testosterone.*

The recommendations of the FDA panel introduce the right course of action, say Carey Danis & Lowe, defective drug lawyers. It is important to test testosterone gel and other testosterone products to better understand their impact on heart health. Furthermore, updating the product labeling is vital in providing healthcare providers and patients with the most up-to-date information on the safety of testosterone products, so that they can make informed health decisions.

Legal Assistance for Alleged Defective Drug Injuries

In addition to staying current on the FDA’s handling of testosterone gel, the legal team and medical professionals at Carey Danis & Lowe are also following the testosterone gel litigation taking place in a federal court in Illinois (U.S. District Court for the Northern District of Illinois, In re: Testosterone Replacement Therapy Product Liability Litigation, MDL no. 2545). As the St. Louis law firm provides legal assistance and representation to individuals who claim to have been injured by testosterone gel, Carey Danis & Lowe delivers their expert analysis on timely topics for the benefit of anyone interested in defective drug law and news.

Carey Danis & Lowe is available to review legal options, compensation eligibility, and health concerns with those who claim injury from testosterone gel products.
Carey Danis & Lowe can be reached by phone at 800.721.2519.

About Carey Danis & Lowe

Carey Danis & Lowe is a plaintiff’s litigation firm based in St. Louis, Missouri with law offices across the United States in Illinois, Missouri, and Florida. Carey Danis & Lowe specializes in defective drug and pharmaceutical litigation and class action lawsuits. The Carey Danis & Lowe team is comprised of experienced attorneys working alongside knowledgeable and professional staff that includes medical doctors, nurses, and information technology specialists. Contact Carey Danis & Lowe at 800.721.2519 for more information about our legal services.

 

Source
Wall Street Journal, “In Men’s Fight Against Aging, How Much Risk to Take?”, Melinda Beck, October 27, 2014: http://bit.ly/wsj-testosterone-replacement-therapy

Lawsuits Involving Yaz Side Effects to Be Heard May 2015

By | Pharmaceutical litigation, Uncategorized, Yaz/Yasmin

yaz_lawsuit_yasmin_side_effects_lawsuits_dvt_blood_clot_settlementsWomen who experienced Yaz side effects involving certain types of blood clot formation, and who filed lawsuits against Yaz and Yasmin manufacturer, Bayer, received good news last month. The federal court hearing Yaz and Yasmin lawsuits set a court date for cases involving women who experienced venous thromboembolism, or the formation of one or more blood clots, in their arteries.

The court will hear these cases in May 2015.

The U.S. District Court for the Southern District of Illinois is location in which thousands of these Yaz and Yasmin lawsuits have been consolidated. Of these, approximately 2,500 involve women who suffered arterial clots and other serious Yaz side effects.

The purpose for scheduling the May 2015 court date is to reach a settlement in these 2,500 cases.

The team of dedicated Yaz lawyers at Carey Danis & Lowe are pleased to hear of this good news, and strongly hope that these cases can be fairly resolved as early as possible next year.

The Yaz lawyers at Carey Danis & Lowe represent women whose lives have been harmed through Yaz or Yasmin use. Our clients have suffered tremendously after using Bayer’s contraceptive drugs, and that is why Carey Danis & Lowe works tirelessly in recouping losses on behalf of these women and their families.

If you or someone you love has been a victim of Yaz or Yasmin use, we encourage you to discover what your legal options and compensation eligibility may be. Our Yaz lawyers are available to review your case during a free, no-obligation consultation.

We invite you to share your Yaz or Yasmin story with us today. Contact Carey Danis & Lowe by phone at 800.721.2519, or by completing a confidential personal injury form.

C.R. Bard Transvaginal Mesh MDL Judge Seeks Efficiency

By | Defective Medical Device litigation, Transvaginal Mesh, Uncategorized

gavel_multidistrict_litigation_settlements_trial_transvaginal_mesh_lawsuitsFeeling that more progress must be made in the C.R. Bard transvaginal mesh multidistrict litigation (MDL), the presiding judge decided to begin reviewing similar cases in bulk sets, what the court is calling “Waves”, to expedite the resolution process for both plaintiffs and defendants. One of the primary reasons for Judge Joseph R. Goodwin’s decision is the ever increasing number of transvaginal mesh lawsuits being consolidated not only into the C.R. Bard MDL, but also into the other six transvaginal mesh MDLs in West Virginia, all of which are being managed by Judge Goodwin.

According to pretrial order (PTO) #131, there are around 9,000 transvaginal mesh lawsuits filed in the C.R. Bard MDL.

Judge Goodwin noted in the PTO that there are over 60,000 cases in all seven of the transvaginal mesh MDLs being heard in a U.S. District Court in West Virginia.

In order to uphold the reason for an MDL’s existence, which in part is “to secure the just, speedy, and inexpensive determination of every action and proceeding”, a rule that Judge Goodwin included in the PTO, the judge ordered that cases in “Wave 3” involve only those wherein the plaintiff received only a C.R. Bard Avaulta product.

After removing cases from Wave 3 that involve products not manufactured by C.R. Bard, the court expects to transfer cases to a federal district court if the cases were filed directly into the C.R. Bard MDL. If the cases were transferred to the MDL, the plan is to transfer those cases back to the federal district court in the state from which the case originated.

The St. Louis law firm of Carey Danis & Lowe is encouraged by Judge Goodwin’s adherence to efficiency in acknowledging that more measurable progress needs to be made in the C.R. Bard MDL. Through sound legal management, such as that displayed by Judge Goodwin, cases can be more swiftly resolved, closing what is for many a chapter of extreme pain and suffering.

Defective Medical Device Lawyers

Carey Danis & Lowe practices defective medical device litigation, and represents women from all over the U.S. who allege injury from C.R. Bard transvaginal mesh products.

If you or someone you love sustained an injury from C.R. Bard transvaginal mesh, or another transvaginal mesh product, our law firm invites you to explore your legal options and compensation eligibility during a free case evaluation.

Share your transvaginal mesh story with Carey Danis & Lowe today. Give us a call at 800.721.2519, or complete a confidential personal injury claim form.

We look forward to assisting you in any way that we can.

U.S. JPML Releases Info on Transvaginal Mesh Lawsuits

By | Defective Medical Device litigation, Transvaginal Mesh, Uncategorized

sealA panel responsible for the management of multidistrict litigation (MDL) across the country, the U.S. Judicial Panel on Multidistrict Litigation (JPML) published a document in mid-June with updated information on open MDLs. Included in the JPML’s document published on June 16, 2014 are the seven MDLs pertaining to transvaginal mesh products.

The transvaginal mesh MDLs are all being heard by U.S. District Judge Joseph R. Goodwin in the U.S. District Court for the Southern District of West Virginia. The MDLs are:

IN RE: American Medical Systems, Inc., Pelvic Repair System Products Liability Litigation, MDL 2325

  • IN RE: Boston Scientific Corp. Pelvic Repair System Products Liability Litigation, MDL 2326
  • IN RE: Ethicon, Inc., Pelvic Repair System Products Liability Litigation, MDL 2327
  • IN RE: Coloplast Corp. Pelvic Support Systems Products Liability Litigation, MDL 2387
  • IN RE: Cook Medical, Inc., Pelvic Repair System Products Liability Litigation, MDL 2440
  • IN RE: Neomedic Pelvic Repair System Products Liability Litigation, MDL 2511

The JPML document provides the number of pending transvaginal mesh lawsuits in each of these MDLs. In the American Medical Systems MDL, there are 17,812 lawsuits pending. There are 12,004 lawsuits pending in the Boston Scientific MDL, 1,468 lawsuits in the Coloplast MDL, 195 lawsuits in the Cook Medical MDL, and 52 lawsuits pending in the Neomedic MDL. The transvaginal mesh MDL with the largest number of pending lawsuits is the Ethicon MDL with 18,176 cases.

According to the JPML numbers, there are just under 60,000 transvaginal mesh lawsuits pending in the West Virginia federal court. This calculation does not include the lawsuits pending in state courts across the country.

The increasing number of lawsuits being filed in state and federal courts demonstrates that transvaginal mesh products have negatively impacted the lives of so many women, and that these women no longer want to remain silent about their pain and suffering.

Carey Danis & Lowe Provides Legal Representation to Victims

From our headquarters in St. Louis, our team of dedicated defective medical device lawyers at Carey Danis & Lowe works diligently for women who have been injured by transvaginal mesh. If you or someone you love has suffered an injury after receiving a transvaginal mesh implant, our lawyers are available to discuss legal options and compensation eligibility in a free initial case evaluation.

Share your transvaginal mesh story with Carey Danis & Lowe today. Give our St. Louis law firm a call at 800.721.2519, or complete a personal injury claim form.